AAAAAA
Results:
1-13
|
Results: 13
Authors:
Thybusch-Bernhardt, A
Aigner, A
Beckmann, S
Czubayko, F
Juhl, H
Citation: A. Thybusch-bernhardt et al., Ribozyme targeting of HER-2 inhibits pancreatic cancer cell growth in vivo, EUR J CANC, 37(13), 2001, pp. 1688-1694
Authors:
Stoppler, H
Malerczyk, C
Block, K
Aigner, A
Czubayko, F
Citation: H. Stoppler et al., The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalizedhuman keratinocytes, ONCOGENE, 20(50), 2001, pp. 7430-7436
Authors:
Aigner, A
Juhl, H
Malerczyk, C
Tkybusch, A
Benz, CC
Czubayko, F
Citation: A. Aigner et al., Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation, ONCOGENE, 20(17), 2001, pp. 2101-2111
Numerical simulations of the flow of a continuously stratified fluid, incorporating inertial effects
Authors:
Aigner, A
Grimshaw, R
Citation: A. Aigner et R. Grimshaw, Numerical simulations of the flow of a continuously stratified fluid, incorporating inertial effects, FLUID DYN R, 28(5), 2001, pp. 323-347
Authors:
Liu, XH
Aigner, A
Wellstein, A
Ray, PE
Citation: Xh. Liu et al., Up-regulation of a fibroblast growth factor binding protein in children with renal diseases, KIDNEY INT, 59(5), 2001, pp. 1717-1728
Authors:
Tassi, E
Al-Attar, A
Aigner, A
Swift, MR
McDonnell, K
Karavanov, A
Wellstein, A
Citation: E. Tassi et al., Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein, J BIOL CHEM, 276(43), 2001, pp. 40247-40253
Authors:
Stoica, GE
Kuo, A
Aigner, A
Sunitha, I
Souttou, B
Malerczyk, C
Caughey, DJ
Wen, DZ
Karavanov, A
Riegel, AT
Wellstein, A
Citation: Ge. Stoica et al., Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin, J BIOL CHEM, 276(20), 2001, pp. 16772-16779
Authors:
Aigner, A
Butscheid, M
Kunkel, P
Krause, E
Lamszus, K
Wellstein, A
Czubayko, F
Citation: A. Aigner et al., An FGF-binding protein (FGF-BP) exerts its biological function by parallelparacrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 release, INT J CANC, 92(4), 2001, pp. 510-517
Authors:
Aigner, A
Malerczyk, C
Houghtling, R
Wellstein, A
Citation: A. Aigner et al., Tissue distribution and retinoid-mediated downregulation of an FGF-bindingprotein (FGF-BP) in the rat, GROW FACTOR, 18(1), 2000, pp. 51
Authors:
Aigner, A
Hsieh, SS
Malerczyk, C
Czubayko, F
Citation: A. Aigner et al., Reversal of HER-2 over-expression renders human ovarian cancer cells highly resistant to taxol, TOXICOLOGY, 144(1-3), 2000, pp. 221-228
Authors:
Hsieh, SS
Malerczyk, C
Aigner, A
Czubayko, F
Citation: Ss. Hsieh et al., ErbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferation, INT J CANC, 86(5), 2000, pp. 644-651
Authors:
Aigner, A
Broutman, D
Grimshaw, R
Citation: A. Aigner et al., Numerical simulations of internal solitary waves with vortex cores, FLUID DYN R, 25(6), 1999, pp. 315-333
Authors:
Wellstein, A
Schulte, AM
Malerczyk, C
Tuveson, AT
Aigner, A
Czubayko, F
Riegel, AT
Citation: A. Wellstein et al., Ribozyme targeting of angiogenic molecules, CANC DRUG, 3, 1999, pp. 423-441
Risultati:
1-13
|